Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial (Q28344103)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial	scientific article

Statements

scholarly article

0 references

Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial (English)

0 references

phase II clinical trial

0 references

multicenter clinical trial

0 references

author name string

C S Peña

1

0 references

S Saini

2

0 references

R L Baron

3

0 references

B A Hamm

4

0 references

G Morana

5

0 references

R Caudana

6

0 references

A Giovagnoni

7

0 references

A Villa

8

0 references

A Carriero

9

0 references

D Mathieu

10

0 references

M W Bourne

11

0 references

M A Kirchin

12

0 references

G Pirovano

13

0 references

A Spinazzi

14

0 references

language of work or name

0 references

publication date

2001

1 reference

Korean journal of radiology : official journal of the Korean Radiological Society

0 references

2

0 references

4

0 references

210-5

0 references

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2001

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718123

20 March 2017

Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718123

29 September 2017

Soluble-type hepatobiliary contrast agents for MR imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718123

29 September 2017

Understanding and optimizing use of contrast material for CT of the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718123

29 September 2017

Gadobenate dimeglumine (Gd-BOPTA). An overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718123

2 June 2018

Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718123

2 June 2018

Interim results of phase II clinical testing of gadobenate dimeglumine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718123

2 June 2018

Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2718123

27 November 2018

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical profile of Gd-BOPTA. A liver-specific MRI contrast agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small hepatocellular carcinoma in patients undergoing liver transplantation: detection with CT after injection of iodized oil

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multihance clinical pharmacology: biodistribution and MR enhancement of the liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gadobenate dimeglumine (BOPTA) enhanced MR imaging: patterns of enhancement in normal liver and cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11754328

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3348/KJR.2001.2.4.210

0 references

release_zkulkpoxl5gypd4ftxsqkjuabu

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28344103&oldid=1871024999"